Spry vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Spry
Best for compounded GLP-1 plus anti-aging peptides under one membershipStarting at $199/mo
Vytora Health
Best for compounded or brand-name GLP-1 with named pharmacy partners, 50 statesStarting at $150/mo
Side-by-Side Comparison
| Feature | Spry | Vytora Health |
|---|---|---|
| Overall Score | 6.1/10 | ✓8.7/10 |
| Starting Price | $199/mo | ✓$150/mo |
| Editorial Rating | 3.1 ★ /5 | ✓4.4 ★ /5 |
| Features | 5 features | ✓8 features |
| States Available | 0 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 1 warning | ✓None |
Pros & Cons
Spry
Pros
- ✓Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- ✓Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- ✓Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- ✓No contracts or commitment required
- ✓LegitScript Certified with a public verification link
- ✓Same-day to 24-hour provider intake review
Cons
- ✗Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- ✗Intake reviewed by a nurse practitioner, not an MD
- ✗States served not disclosed publicly
- ✗Pharmacy partner not named, and 503A vs 503B designation not specified
- ✗Corporate legal entity not disclosed
- ✗Co-founder credentials not disclosed
- ✗Includes BPC-157, an unregulated peptide with limited human efficacy data, reflecting a functional-medicine slant
Vytora Health
Pros
- ✓All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- ✓Both compounded and brand-name options on one platform — uncommon
- ✓LegitScript Approved and HIPAA compliant
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- ✓Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- ✓Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Cons
- ✗Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- ✗Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- ✗Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- ✗Initial consultation cost not shown on the public pricing page
- ✗Limited per-prescriber state licensure detail
Our Verdict
Vytora Health edges out Spry with a higher overall score of 8.7/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Spry remains a solid alternative, especially if you're looking for compounded GLP-1 plus anti-aging peptides under one membership.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Spry and Vytora Health head-to-heads in the same category.
- Spry vs CoreAge Rx
- Spry vs TrimRx
- Spry vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.